126 related articles for article (PubMed ID: 20428831)
1. Differential roles of leptin in regulating cell migration in thyroid cancer cells.
Cheng SP; Yin PH; Chang YC; Lee CH; Huang SY; Chi CW
Oncol Rep; 2010 Jun; 23(6):1721-7. PubMed ID: 20428831
[TBL] [Abstract][Full Text] [Related]
2. Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.
Zhuravel OV; Gerashchenko OL; Khetsuriani MR; Soldatkina MA; Pogrebnoy PV
Exp Oncol; 2014 Sep; 36(3):174-8. PubMed ID: 25265350
[TBL] [Abstract][Full Text] [Related]
3. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
[TBL] [Abstract][Full Text] [Related]
4. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
5. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
6. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
PLoS One; 2017; 12(2):e0172315. PubMed ID: 28207834
[TBL] [Abstract][Full Text] [Related]
7. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
[TBL] [Abstract][Full Text] [Related]
8. Role of the endothelin axis in the proliferation of human thyroid cancer cells.
Donckier JE; Mertens-Strijthagen J; Flamion B
Clin Endocrinol (Oxf); 2007 Oct; 67(4):552-6. PubMed ID: 17561979
[TBL] [Abstract][Full Text] [Related]
9. Expression, regulation and function of autotaxin in thyroid carcinomas.
Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
[TBL] [Abstract][Full Text] [Related]
10. Fibrillin expression and localization in various types of carcinomas of the thyroid gland.
Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Litsiou H; Sozopoulos E; Balafoutas D; Patsouris E
Mod Pathol; 2006 May; 19(5):695-700. PubMed ID: 16528372
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
12. Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.
Cerutti JM; Ebina KN; Matsuo SE; Martins L; Maciel RM; Kimura ET
J Endocrinol Invest; 2003 Jun; 26(6):516-21. PubMed ID: 12952364
[TBL] [Abstract][Full Text] [Related]
13. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
14. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
15. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
[TBL] [Abstract][Full Text] [Related]
16. Role of glutaminyl cyclases in thyroid carcinomas.
Kehlen A; Haegele M; Menge K; Gans K; Immel UD; Hoang-Vu C; Klonisch T; Demuth HU
Endocr Relat Cancer; 2013 Feb; 20(1):79-90. PubMed ID: 23183267
[TBL] [Abstract][Full Text] [Related]
17. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
Fan YL; Li XQ
Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors.
Xu J; Filetti S; Hershman JM
Thyroid; 2008 May; 18(5):533-9. PubMed ID: 18399756
[TBL] [Abstract][Full Text] [Related]
19. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways.
Cheng SP; Yin PH; Hsu YC; Chang YC; Huang SY; Lee JJ; Chi CW
Oncol Rep; 2011 Nov; 26(5):1265-71. PubMed ID: 21750869
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW; Rougier JP; Park JW; Duh QY; Wong M; Werb Z; Clark OH
Endocr Relat Cancer; 2006 Dec; 13(4):1173-83. PubMed ID: 17158762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
